AVANIR PHARMACEUTICALS INC's ticker is and the CUSIP is 05348P951. A total of 2 filers reported holding AVANIR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $459,000 | -28.2% | 27,100 | -49.4% | 0.00% | -100.0% |
| Q3 2014 | $639,000 | +643.0% | 53,600 | +252.6% | 0.00% | – |
| Q2 2014 | $86,000 | -14.9% | 15,200 | -44.9% | 0.00% | – |
| Q1 2014 | $101,000 | +50.7% | 27,600 | +39.4% | 0.00% | – |
| Q4 2013 | $67,000 | -60.8% | 19,800 | -51.0% | 0.00% | – |
| Q3 2013 | $171,000 | +51.3% | 40,400 | +64.9% | 0.00% | – |
| Q2 2013 | $113,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 567,300 | $6,762,000 | 0.10% |
| Citadel Advisors | 53,600 | $639,000 | 0.00% |